Literature DB >> 18562749

MR cholangiopancreatography features of the biliary tree after liver transplantation.

Sébastien Novellas1, Thomas Caramella, Maud Fournol, Jean Gugenheim, Patrick Chevallier.   

Abstract

OBJECTIVE: Our objective was to show the usefulness of MR cholangiopancreatography in assessing biliary complications after liver transplantation.
CONCLUSION: MR cholangiopancreatography is the best noninvasive tool for the diagnosis and assessment of biliary complications.

Mesh：

Year:  2008        PMID： 18562749     DOI： 10.2214/AJR.07.2938

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


  6 in total

1.  Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.

Authors:  Laetitia Nguyen; Nora Cazzagon; Christophe Corpechot; Sanaâ El Mouhadi; Sara Lemoinne; Olivier Chazouillères; Lionel Arrivé
Journal:  Eur Radiol       Date:  2018-08-29       Impact factor: 5.315

2.  Imaging follow-up after liver transplantation.

Authors:  Michele Di Martino; Massimo Rossi; Gianluca Mennini; Fabio Melandro; Michele Anzidei; Silvia De Vizio; Kameliya Koryukova; Carlo Catalano
Journal:  Br J Radiol       Date:  2016-06-10       Impact factor: 3.039

Review 3.  Endoscopic management of biliary complications after liver transplantation: An evidence-based review.

Authors:  Carlos Macías-Gómez; Jean-Marc Dumonceau
Journal:  World J Gastrointest Endosc       Date:  2015-06-10

Review 4.  Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation.

Authors:  Moustafa Mabrouk Mourad; Abdullah Algarni; Christos Liossis; Simon R Bramhall
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Role of multi-detector computed tomography for biliary complications after liver transplantation.

Authors:  Xiao-Chun Meng; Wen-Sou Huang; Pei-Yi Xie; Xiu-Zhen Chen; Ming-Yue Cai; Hong Shan; Kang-Shun Zhu
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

6.  Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.

Authors:  Changjun Huang; Shanzhou Huang; Yunhua Tang; Qiang Zhao; Dongping Wang; Weiqiang Ju; Lu Yang; Jian Zhang; Linwei Wu; Maogen Chen; Zhiheng Zhang; Zebin Zhu; Linhe Wang; Caihui Zhu; Yixi Zhang; Chengjun Sun; Wei Xiong; Yuekun Shen; Xiaoxiang Chen; Yi Ma; Anbin Hu; Xiaofeng Zhu; Jian Rong; Changjie Cai; Zhiyong Guo; Xiaoshun He
Journal:  BMJ Open       Date:  2020-05-05       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.